- Home
- LLY vs JPM Comparison
LLY vs JPM Comparison
Compare LLY & JPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$942.51
Company Overview
Basic Information| Metric | LLY | JPM |
|---|---|---|
| Founded | 1876 | 1799 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 818.6B | 816.0B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | LLY | JPM |
|---|---|---|
| Price | $942.51 | $308.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 15 |
| Target Price | ★ $1,217.05 | $330.53 |
| AVG Volume (30 Days) | 2.3M | ★ 8.3M |
| Earning Date | 04-30-2026 | 04-14-2026 |
| Dividend Yield | 0.72% | ★ 1.93% |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 22.95 | N/A |
| Revenue | ★ $65,179,000,000.00 | N/A |
| Revenue This Year | $26.98 | $17.57 |
| Revenue Next Year | $15.83 | $3.84 |
| P/E Ratio | $41.65 | ★ $15.42 |
| Revenue Growth | ★ 44.70 | N/A |
| 52 Week Low | $623.78 | $226.34 |
| 52 Week High | $1,133.95 | $337.25 |
Technical Indicators
Market Signals| Indicator | LLY | JPM |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 64.41 |
| Support Level | $877.11 | $293.95 |
| Resistance Level | $976.68 | $315.06 |
| Average True Range (ATR) | 24.65 | 6.09 |
| MACD | 8.34 | 2.90 |
| Stochastic Oscillator | 69.20 | 91.39 |
Price Performance
Historical Comparison LLY
JPM
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
About JPM JP Morgan Chase & Co.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with more than $4.4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates and is subject to regulation in multiple countries.